Another layer of complexity was introduced by the fact that knock-down of BCR-ABL1 in CD34+ human CML stems cells fails to efficiently eradicate these leukemic cells [68]. The gene discussed is CD34; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.